Assessment of dual-energy x-ray absorptiometry measures of bone health in pediatric chronic kidney disease
Dual-energy X-ray absorptiometry (DXA) techniques are limited in childhood chronic kidney disease (CKD) by the confounding effect of short stature and opposing parathyroid hormone effects on trabecular and cortical bone. Peripheral quantitative computed tomography (pQCT) is not subject to these limitations.
Lumbar spine (LS) and whole-body (WB) DXA and tibia pQCT scans were obtained in 88 stage 4–5 CKD and >650 healthy participants, ages 5–21 years. Sex- and race-specific Z-scores were generated for bone mineral density (BMD) and bone mineral content (BMC) by DXA, relative to age and adjusted for height Z-score (LS-BMD-Z and WB-BMC-Z), and compared to pQCT Z-scores for trabecular BMD (TrabBMD-Z) for age and cortical BMC (CortBMC-Z) for age and tibia length.
LS-BMD-Z [0.50 (95% C.I. 0.28, 0.73), p < 0.0001] and TrabBMD-Z [0.53 (0.27, 0.79), p < 0.0001] were greater in CKD, and WB-BMC-Z [–0.36 (–0.53, –0.19), p < 0.0001] and CortBMC-Z [–0.48 (–0.70, –0.27), p < 0.0001] were lower, compared to reference participants. Z-scores were correlated at trabecular (LS-BMD-Z and TrabBMD-Z: R = 0.36) and cortical (WB-BMC-Z and CortBMC-Z: R = 0.64) sites in CKD; similar to correlations in reference participants.
Lumbar spine and whole-body DXA suggested greater trabecular BMD and lower cortical BMC in CKD, consistent with pQCT results; however, correlations were modest. Studies are needed to identify methods that predict fracture in childhood CKD.
KeywordsPediatrics Bone Dual-energy X-ray absorptiometry Peripheral quantitative computed tomography Chronic kidney disease
NIH R01-DK060030, R01-HD040714, K24-DK076808, and UL1-RR-024134
- 1.NIH Osteoporosis Prevention, Diagnosis, and Therapy (2000) NIH Consensus Statement 17(1):1–36Google Scholar
- 3.Bishop N, Braillon P, Burnham J, Cimaz R, Davies J, Fewtrell M, Hogler W, Kennedy K, Makitie O, Mughal Z, Shaw N, Vogiatzi M, Ward K, Bianchi ML (2008) Dual-energy X-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11(1):29–42PubMedCrossRefGoogle Scholar
- 7.Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, Mahboubi S, Shepherd JA, Hangartner TN, Frederick MM, Winer KK, Kalkwarf HJ (2010) Height adjustment in assessing dual-energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265–1273PubMedCrossRefGoogle Scholar
- 9.Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the Bone Mineral Density in Childhood Study. J Clin Endocrinol Metab 96:3160–3169PubMedCrossRefGoogle Scholar
- 12.Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell Scientific Publications, OxfordGoogle Scholar
- 13.Tanner JM, Whitehouse RH, Marshall WA, Healy MJR, Goldstein H (1975) Assessment of skeletal maturity and prediction of adult height (TW2 method). Academic Press, LondonGoogle Scholar
- 14.Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, Lorenc RS, Tosi LL, Ward KA, Ward LM, Kalkwarf HJ (2008) Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11:43–58PubMedCrossRefGoogle Scholar
- 17.Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16(4):605–614PubMedCrossRefGoogle Scholar
- 18.Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109(1):45–60PubMedCrossRefGoogle Scholar
- 26.KDOQI Clinical Practice Guidelines for bone metabolism and disease in children with chronic kidney disease (2005) Am J of Kid Diseases 46(1):S1–S103Google Scholar
- 27.KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) (2009) Kidney Int 76(113):S1Google Scholar
- 35.van der Sluis IM, Boot AM, Nauta J, Hop WC, de Jong MC, Lilien MR, Groothoff JW, van Wijk AE, Pols HA, Hokken-Koelega AC, de Muinck Keizer-Schrama SM (2000) Bone density and body composition in chronic renal failure: effects of growth hormone treatment. Pediatr Nephrol 15(3–4):221–228PubMedCrossRefGoogle Scholar